参考文献
［1］ Choi DW.Bench to bedside：the glutamate connection［J］.Science，1992，258（5080）：241-243.
［2］ Butler D.Translational research：crossing the valley of death［J］.Nature，2008，453（7197）：840-842.
［3］ Forsmark CE，Vege SS，Wilcox CM.Acute pancreatitis［J］.New England Journal of Medicine，2016，375（20）：1972-1981.
［4］ Setiawan VW，Pandol SJ，Porcel J，et al.Dietary factors reduce risk of acute pancreatitis in a large multiethnic cohort［J］.Clinical Gastroenterology &Hepatology the Official Clinical Practice Journal of the American Gastroenterological Association，2016，15（2）：257.
［5］ Sadr-Azodi O，Andrén-SandbergÅ，Orsini N，et al.Cigarette smoking，smoking cessation and acute pancreatitis：aprospective population-based study［J］.Gut，2012，61（2）：262.
［6］ Sadr-Azodi O，Mattsson F，Bexlius TS，et al.Association of oral glucocorticoid use with an increased risk of acute pancreatitis：apopulation-based nested case-control study［J］.Jama Internal Medicine，2013，173（6）：444.
［7］ Samad A，James A，Wong J，et al.Insulin protects pancreatic acinar cells from palmitoleic acid-induced cellular injury［J］.Journal of Biological Chemistry，2014，289（34）：23582.
［8］ Mashima H，Sato T，Horie Y，et al.Interferon regulatory factor-2regulates exocytosis mechanisms mediated by SNAREs in pancreatic acinar cells［J］.Gastroenterology，2011，141（3）：1102.
［9］ Li L，Shen J，Bala MM，et al.Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus：systematic review and meta-analysis of randomised and non-randomised studies［J］.Bmj，2014，348（8）：g2366.
［10］ Faillie JL，Azoulay L，Patenaude V，et al.Incretin based drugs and risk of acute pancreatitis in patients with type 2diabetes：cohort study［J］.BMJ，2014，348.
［11］ Hu G，Shen J，Cheng L，et al.Reg4protects against acinar cell necrosis in experimental pancreatitis［J］.Gut，2011，60（6）：820.
［12］ Capurso G，Boccia S，Salvia R，et al.Risk factors for intraductal papillary mucinous neoplasm（IPMN）of the pancreas：a multicentre case-control study［J］.American Journal of Gastroenterology，2013，108（6）：1003.
［13］ Wu Q，Chen G，Wu WM，et al.Metabolic syndrome components and risk factors for pancreatic adenocarcinoma：a case-control study in China［J］.Digestion，2012，86（4）：294.
［14］ Whitcomb DC，Larusch J，Krasinskas AM，et al.Common genetic variants in the CLDN2and PRSS1-PRSS2loci alter risk for alcohol-related and sporadic pancreatitis［J］.Nature Genetics，2012，44（12）：1349-1354.
［15］ Larusch J，Lozanoleon A，Stello K，et al.The Common Chymotrypsinogen C（CTRC）variant G60G（C.180T）increases risk of chronic pancreatitis but not recurrent acute pancreatitis in a north american population［J］.Clinical &Translational Gastroenterology，2015，6：e68.
［16］ Heap GA，Weedon MN，et al.HLA-DQA1-HLA-DRB1variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants［J］.Nature Genetics，2014，46（10）：1131-1134.
［17］ Xue J，Sharma V，Hsieh M H，et al.Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis［J］.Nature Communications，2015，6：7158.(https://www.daowen.com)
［18］ Awla D，Zetterqvist AV，Abdulla A，et al.NFATc3regulates trypsinogen activation，neutrophil recruitment，and tissue damage in acute pancreatitis in mice［J］.Gastroenterology，2012，143（5）：1352-1360.
［19］ Fan CJ，Hirose K，Walsh CM，et al.Laparoscopic total pancreatectomy with islet autotransplantation and intraoperative islet separation as a treatment for patients with chronic pancreatitis［J］.Jama Surgery，2017，152（6）：550-556.
［20］ 刘碧霞，李清林.MicroRNAs在胃肠胰腺神经内分泌肿瘤中的临床应用［J］.中国医学创新，2016，13（35）：139-143.
［21］ 中华医学会外科学分会胰腺外科学组.胰腺神经内分泌肿瘤治疗指南（2014版）［J］.中华消化外科杂志，2014，13（12）：919-922.
［22］ 中国临床肿瘤学会神经内分泌肿瘤专家委员会.中国胃肠胰神经内分泌肿瘤专家共识（2016年版）［J］.临床肿瘤学杂志，2016，21（10）：927-946.
［23］ Scarpa A，Chang D K，Nones K，et al.Whole-genome landscape of pancreatic neuroendocrine tumours［J］.Nature，2017，543（7643）：65.
［24］ Cao Y，Gao Z，Li L，et al.Whole exome sequencing of insulinoma reveals recurrent T372Rmutations in YY1［J］.Nature Communications，2013，4（4）：2810.
［25］ Soler A，Figueiredo AM，Castel P，et al.Therapeutic benefit of selective inhibition of p110αPI3-kinase in pancreatic neuroendocrine tumors［J］.Clinical Cancer Research An Official Journal of the American Association for Cancer Research，2016，22（23）：5805.
［26］ Qian ZR，Rubinson DA，Nowak JA，et al.Association of alterations in main driver genes with outcomes of patients with resected pancreatic ductal adenocarcinoma［J］.Jama Oncology，2017.
［27］ Krebs AM，Mitschke J，Lasierra LM，et al.The EMT-activator Zeb1is a key factor for cell plasticity and promotes metastasis in pancreatic cancer［J］.Nature Cell Biology，2017，19（5）：518.
［28］ Yang KS，Im H，Hong S，et al.Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy［J］.Science Translational Medicine，2017，9（391）：eaal3226.
［29］ Cohen JD，Javed AA，Thoburn C，et al.Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers［J］.Proceedings of the National Academy of Sciences of the United States of America，2017，114（38）.
［30］ Geller LT，Barzilyrokni M，Danino T，et al.Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine［J］.Science，2017，357（356）：1156-1160.
［31］ Jiang H，Hegde S，Knolhoff BL，et al.Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy［J］.Nature Medicine，2016，22（8）：851-860.
［32］ Muranen T，Iwanicki MP，Curry NL，et al.Starved epithelial cells uptake extracellular matrix for survival［J］.Nature Communications，2017，8：13989.
［33］ Ruivo CF，Sugimoto H，Lee JJ，et al.Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer［J］.Nature，2017，546（7659）：498-503.